Interestingly, 9/16 CLL samples showed a bimodal downregulation of HLA-E in response to selinexor, perhaps reflecting increased sensitivity of certain CLL sub-populations to HLA-E downregulation. Here, HLA-E is linked to B-cell chronic lymphocytic leukemia.